GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

WGS GeneDx Holdings

Closed 01-06 16:00:00 EST

135.80

+4.30

+3.27%

盘后135.80

+0.000.00%

19:39 EST

High135.97	Low128.00	Vol233.48K
Open130.66	D1 Closing131.50	Amplitude6.06%
Mkt Cap3.93B	Tradable Cap2.71B	Total Shares28.90M
T/O31.23M	T/O Rate1.17%	Tradable Shares19.94M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

Loading ...

{"stockData":{"symbol":"WGS","market":"US","secType":"STK","nameCN":"GeneDx Holdings","latestPrice":135.8,"timestamp":1767733200000,"preClose":131.5,"halted":0,"volume":233483,"hourTrading":{"tag":"盘后","latestPrice":135.8,"preClose":135.8,"latestTime":"19:39 EST","volume":6431,"amount":873366.755,"timestamp":1767746342639},"delay":0,"floatShares":19944938,"shares":28904590,"eps":0.073539,"marketStatus":"Closed","change":4.3,"latestTime":"01-06 16:00:00 EST","open":130.66,"high":135.97,"low":128,"amount":31227431.32698,"amplitude":0.060608,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.073539,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1767776400000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":131.5,"preHourTrading":{"tag":"盘前","latestPrice":128.75,"preClose":131.5,"latestTime":"09:21 EST","volume":159,"amount":20679.25857,"timestamp":1767709291025},"postHourTrading":{"tag":"盘后","latestPrice":135.8,"preClose":135.8,"latestTime":"19:39 EST","volume":6431,"amount":873366.755,"timestamp":1767746342639},"volumeRatio":0.550259,"impliedVol":0.8986,"impliedVolPercentile":0.584},"requestUrl":"/m/hq/s/WGS","defaultTab":"news","newsList":[{"id":"2601672890","title":"GeneDx Appoints Dr. Linda Genen as Chief Medical Officer","url":"https://stock-news.laohu8.com/highlight/detail?id=2601672890","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601672890?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:30","pubTimestamp":1767706246,"startTime":"0","endTime":"0","summary":"GeneDx Holdings Corp. has appointed Dr. Linda Genen, MD, MPH as Chief Medical Officer. Dr. Genen will lead the company's medical and clinical affairs, shape clinical strategy, and work to expand the adoption of genomic medicine in healthcare. She joins GeneDx from ProgenyHealth, where she previously served as Chief Medical Officer.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire  on January 06, 2026, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nNDL9x0mSr:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2601555890","title":"GeneDx Appoints DR. Linda Genen as Chief Medical Officer to Accelerate the Future of Genomic-First Care","url":"https://stock-news.laohu8.com/highlight/detail?id=2601555890","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601555890?lang=en_us&edition=fundamental","pubTime":"2026-01-06 21:30","pubTimestamp":1767706203,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260106:nTUA6MF9LP:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2601809884","title":"GeneDx Achieves Record Research Milestones with Landmark Rare Disease Genomics Studies in 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2601809884","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2601809884?lang=en_us&edition=fundamental","pubTime":"2026-01-05 21:30","pubTimestamp":1767619850,"startTime":"0","endTime":"0","summary":"GeneDx Holdings Corp. announced a record-setting year in 2025 for its Medical Affairs and research programs, publishing 79 peer-reviewed studies and surpassing a total of 1,100 publications related to rare disease genomics. Among the most notable was the GUARDIAN  study, which received recognition in JAMA's annual Research of the Year Roundup for its findings on the effectiveness of genomic newborn screening in identifying serious, actionable childhood conditions beyond traditional methods. In addition, GeneDx advanced genome-first clinical care with publications such as SeqFirst Neo, supporting rapid genome sequencing for critically ill newborns, and SeqFirst Floor, demonstrating first-tier rapid genome sequencing in non-critical pediatric wards. These results have already been published. The company also reported contributions to 56 GeneMatcher publications in 2025, facilitating global collaboration and resulting in 31 newly clinically validated gene-disease associations.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260105:nNDLc7y1Qj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2593809774","title":"GeneDx Holdings Is Maintained at Buy by Canaccord Genuity","url":"https://stock-news.laohu8.com/highlight/detail?id=2593809774","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2593809774?lang=en_us&edition=fundamental","pubTime":"2025-12-22 21:14","pubTimestamp":1766409240,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 22, 2025 08:14 ET (13:14 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS"],"gpt_icon":0},{"id":"2592964491","title":"GeneDx Holdings Corp : Jefferies Raises Target Price to $180 From $150","url":"https://stock-news.laohu8.com/highlight/detail?id=2592964491","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2592964491?lang=en_us&edition=fundamental","pubTime":"2025-12-17 15:25","pubTimestamp":1765956301,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251217:nFWN3XN0E3:5","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2591626566","title":"GeneDx Holdings Is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2591626566","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2591626566?lang=en_us&edition=fundamental","pubTime":"2025-12-16 02:28","pubTimestamp":1765823280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 15, 2025 13:28 ET (18:28 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4504","LU0683600562.USD","LU1267930227.SGD","LU0048573561.USD","LU2361044865.SGD","LU0130102774.USD","LU1280957306.USD","WGS","LU0211327993.USD","LU0417517546.SGD","BK4501","LU1074936037.SGD","LU0477156953.USD","LU2461242641.AUD","LU0256863811.USD","LU0742534661.SGD","LU0154236417.USD","LU0029864427.USD","BK4196","LU0708994859.HKD","LU0128525689.USD","LU1814569148.SGD","BK4588","IE000M9KFDE8.USD","LU0971096721.USD","BK4585","LU0640476718.USD","LU0267386448.USD","LU1506573853.SGD","BK4559","LU0251142724.SGD","LU0208291251.USD","LU0052756011.USD","LU0162691827.USD","LU0868494617.USD","LU0149725797.USD","LU2236285917.USD","LU2361045086.USD","LU0310800965.SGD","LU0128525929.USD","LU0106831901.USD","IE00B7SZLL34.SGD","LU0320765489.SGD","LU0314106906.USD","LU0251131958.USD","LU1035773651.USD","LU0310799852.SGD","LU0211328371.USD","LU0072461881.USD","LU1201861249.SGD"],"gpt_icon":0},{"id":"2590508094","title":"GeneDx Holdings Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2590508094","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2590508094?lang=en_us&edition=fundamental","pubTime":"2025-12-12 19:18","pubTimestamp":1765538280,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  December 12, 2025 06:18 ET (11:18 GMT)","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS"],"gpt_icon":0},{"id":"2586260465","title":"Director Joshua Ruch Reports Sale of Genedx Holdings Corp. Common Shares","url":"https://stock-news.laohu8.com/highlight/detail?id=2586260465","media":"Reuters","labels":["shareholding","insiderTrades","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2586260465?lang=en_us&edition=fundamental","pubTime":"2025-11-27 05:14","pubTimestamp":1764191675,"startTime":"0","endTime":"0","summary":"Joshua Ruch, Director of Genedx Holdings Corp., has reported a disposal of common shares of the company. The full filing can be accessed through the link below.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on November 26, 2025, and is solely responsible for the information contained therein.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251126:nNDL6T10pJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Director Joshua Ruch Reports Sale of Genedx Holdings Corp. Common Shares","news_tag":"shareholding,insiderTrades,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2584957221","title":"6 Healthcare Stocks With Strong Upward Momentum","url":"https://stock-news.laohu8.com/highlight/detail?id=2584957221","media":"Benzinga_recent_news","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584957221?lang=en_us&edition=fundamental","pubTime":"2025-11-19 01:59","pubTimestamp":1763488740,"startTime":"0","endTime":"0","summary":"Out with the old , in with the new . After several volatile weeks, it appears a full-fledged rotation has begun with investors fleeing previously high-flying tech winners in favor of underserved healthcare stocks.The rotation has technical and fundamental tailwinds too, as healthcare earnings have been strong and several stocks are breaking out into new uptrends.Today, we'll look at six stocks in the healthcare sector that have been surging higher for a variety of reasons and score well on Benzinga’s Momentum rankings.Benzinga Edge helps you stay ahead with real-time data, stock rankings, and exclusive analyst insights. Spot opportunity before the headlines hit and secure full access for 65% off.Now let's jump to the biotech sector with Abivax , a French pharmaceutical developer focused on chronic inflammatory diseases. The compa","market":"us","thumbnail":"https://cdn.benzinga.com/files/images/story/2025/11/18/Healthcare-stocks.jpeg?optimize=medium&dpr=2&auto=webp&width=240","type":0,"news_type":0,"thumbnails":["https://cdn.benzinga.com/files/images/story/2025/11/18/Healthcare-stocks.jpeg?optimize=medium&dpr=2&auto=webp&width=240"],"rights":{"source":"benzinga_recent_news","url":"https://www.benzinga.com/trading-ideas/movers/25/11/48931956/6-healthcare-stocks-with-strong-upward-momentum","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/trading-ideas/movers/25/11/48931956/6-healthcare-stocks-with-strong-upward-momentum","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"benzinga_recent_news","symbols":["LABU","BK4139","USAW.SI","LU0310799852.SGD","QID","LU1571399168.USD","BK4535","BK4196","LU0310800965.SGD",".IXIC","TQQQ","PSQ","LU0128525689.USD","LU0211328371.USD","XLV","LU0154236417.USD","LU2065171402.SGD","XBI","BK4175","NVIW.SI","LU1267930490.SGD","ABVX","GH","TSYW.SI","ELAN","QLD","LU0006061336.USD","LU1880398471.USD","BK4121","LU2065169927.USD","BK4551","MEDP","USJW.SI","LU2065170008.USD","LU0889566641.SGD","SQQQ","SMA","BK4137","LU2065171311.SGD","NQmain","LU1880398554.USD","WGS","BK4588","BK4581","HCSG","LU0072461881.USD","LU1941712348.USD","MNQmain","CAH"],"gpt_icon":1},{"id":"2584335621","title":"3 Stocks Estimated To Be Trading Below Their Intrinsic Value In November 2025","url":"https://stock-news.laohu8.com/highlight/detail?id=2584335621","media":"Simply Wall St.","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2584335621?lang=en_us&edition=fundamental","pubTime":"2025-11-17 19:08","pubTimestamp":1763377680,"startTime":"0","endTime":"0","summary":"In the current climate of mixed market performance, with the Dow Jones Industrial Average experiencing fluctuations and tech stocks facing valuation concerns, investors are keenly observing opportunities for potential undervalued assets. As we explore three stocks estimated to be trading below their intrinsic value in November 2025, understanding what constitutes a good investment becomes crucial—particularly in identifying companies that may offer strong fundamentals and growth potential...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/4121000-choice1-main-header/1585186790255","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/4121000-choice1-main-header/1585186790255"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/consumer-durables/nyse-onon/on-holding/news/3-stocks-estimated-to-be-trading-below-their-intrinsic-value-14","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/consumer-durables/nyse-onon/on-holding/news/3-stocks-estimated-to-be-trading-below-their-intrinsic-value-14","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["LU2210150020.SGD","LU0289739343.SGD","LU0353189763.USD","LU0069063385.USD","LU2756315664.SGD","LU2361044865.SGD","BK4207","LU2265009873.SGD","LU2458330169.SGD","TMDX","ONB","KRMD","BK4588","CRM","LU0511384066.AUD","LU2361044949.HKD","LU2361045086.USD","WGS","BK4561","LU0109392836.USD","CNH","LU1267930490.SGD","HBAN","HCC","BUSE","LU0353189680.USD","LU0719512351.SGD","LU2458330243.SGD","BK4023","CCNE","CRM.AU","IE00BZ9MQY76.HKD","LU2210149790.SGD","WIX","BK4527","LU0289961442.SGD","LU0251142724.SGD","LU0345780950.USD","BK4196","LU0648001328.SGD","HUBS","LU0234570918.USD","LU0820561818.USD","LU1823568750.SGD","ONON","LU2095319765.USD","LU0251131958.USD","LU0943347566.SGD","LU0128526141.USD","FITB"],"gpt_icon":0},{"id":"2582982868","title":"U.S. RESEARCH ROUNDUP-DoorDash, Honeywell, Zscaler","url":"https://stock-news.laohu8.com/highlight/detail?id=2582982868","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2582982868?lang=en_us&edition=fundamental","pubTime":"2025-11-10 15:58","pubTimestamp":1762761488,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-DoorDash, Honeywell, ZscalerNov 10 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including DoorDash, Honey","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251110:nL4N3WM0IV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["HUN","HPP","GH","MKTX","ATMU","BAM","CSR","MCK","ILMN","APA","IONS","EVTC","BK4565","HTH","CTRE","GPOR","BEN","WGS","LU0432979614.USD","CHRD","HOG","ZS","CF","ACVA","LU0320765646.SGD","OBDC","CTEV","CC","LXU","LU2112291526.USD","LH","ALB","LU2065171402.SGD","CRL","LU2357125470.USD","DRS","BMY","HON","CRC","LAW","CBNK","COR","CPT","DASH","BP","DV","LU1861559042.SGD","DKNG","LU0061475181.USD","FNF"],"gpt_icon":0},{"id":"2581209365","title":"GeneDx Holdings Corp. to Showcase Genomic Advancements at NSGC Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2581209365","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581209365?lang=en_us&edition=fundamental","pubTime":"2025-11-06 21:02","pubTimestamp":1762434158,"startTime":"0","endTime":"0","summary":"Genedx Holdings Corp. will attend the 2025 National Society of Genetic Counselors  Annual Meeting, taking place in November 2025. At the event, Genedx will showcase advancements in gene-disease discovery, long-read sequencing, and the use of their Infinity rare disease dataset. The company will present research findings in four key sessions, highlighting innovations that improve diagnostic accuracy and expand access to precision medicine.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Genedx Holdings Corp. published the original content used to generate this news brief via Business Wire  on November 06, 2025, and is solely responsible for the information contained therein.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251106:nNDL93Zjzh:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"2581796496","title":"GeneDx (WGS): Assessing Valuation After Upbeat Earnings, Raised Guidance, and $100M Equity Offering","url":"https://stock-news.laohu8.com/highlight/detail?id=2581796496","media":"Simply Wall St.","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581796496?lang=en_us&edition=fundamental","pubTime":"2025-11-05 03:38","pubTimestamp":1762285084,"startTime":"0","endTime":"0","summary":"GeneDx Holdings (WGS) caught attention after it reported higher quarterly revenue, raised its full-year forecast, and announced a $100 million equity offering. These moves signal shifting financial momentum and potential implications for investors.\nSee our latest analysis for GeneDx Holdings.\nGeneDx Holdings’ recent upbeat earnings report and guidance upgrade have clearly energized investors. This is reflected in a 16.95% 1-month share price return and an impressive 84.01% total shareholder...","market":"sg","thumbnail":"https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683","type":0,"news_type":0,"thumbnails":["https://images.simplywall.st/asset/industry/9551730-choice2-main-header/1585186975683"],"rights":{"source":"simplywall_highlight","url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/genedx-wgs-assessing-valuation-after-upbeat-earnings-raised","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://simplywall.st/stocks/us/healthcare/nasdaq-wgs/genedx-holdings/news/genedx-wgs-assessing-valuation-after-upbeat-earnings-raised","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"simplywall_highlight","symbols":["WGS","EQR"],"gpt_icon":0},{"id":"2581759478","title":"GeneDx Holdings Is Maintained at Equal-Weight by Wells Fargo","url":"https://stock-news.laohu8.com/highlight/detail?id=2581759478","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2581759478?lang=en_us&edition=fundamental","pubTime":"2025-11-05 00:16","pubTimestamp":1762272960,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 04, 2025 11:16 ET (16:16 GMT)","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1267930573.SGD","LU0072461881.USD","LU0868494708.USD","LU1267930490.SGD","IE00B7SZLL34.SGD","LU0477156953.USD","LU1791807156.HKD","LU1363072403.SGD","IE00B19Z3B42.SGD","LU0128525689.USD","LU0314106906.USD","LU0251142724.SGD","LU0211327993.USD","BK4207","LU0267386448.USD","BK4585","LU0310799852.SGD","IE0002270589.USD","LU1814569148.SGD","BK4504","LU0211328371.USD","LU2361045086.USD","WGS","IE000M9KFDE8.USD","LU0320765489.SGD","LU1201861249.SGD","BK4501","LU0149725797.USD","IE00B19Z3581.USD","LU0052756011.USD","LU0130517989.USD","LU0106831901.USD","LU0048573561.USD","LU0971096721.USD","LU0742534661.SGD","LU0130102774.USD","LU0289960550.SGD","LU1280957306.USD","LU0154236417.USD","LU2236285917.USD","LU0029864427.USD","LU0787776722.HKD","LU0980610538.SGD","LU0070302665.USD","LU1668664300.SGD","LU0868494617.USD","LU1074936037.SGD","LU0417517546.SGD","LU0942090050.USD","BK4196"],"gpt_icon":0},{"id":"2579110121","title":"William O'Neil Initiates GeneDx Holdings at Buy","url":"https://stock-news.laohu8.com/highlight/detail?id=2579110121","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579110121?lang=en_us&edition=fundamental","pubTime":"2025-10-30 19:15","pubTimestamp":1761822952,"startTime":"0","endTime":"0","summary":"GeneDx Holdings (WGS) has an average rating of buy and mean price target of $151.22, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major ban","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["WGS","BK4196"],"gpt_icon":0},{"id":"1122858501","title":"Stock Track | GeneDx Holdings Soars 5.11% as Multiple Analysts Raise Price Targets","url":"https://stock-news.laohu8.com/highlight/detail?id=1122858501","media":"Stock Track","labels":["movement"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1122858501?lang=en_us&edition=fundamental","pubTime":"2025-10-29 23:03","pubTimestamp":1761750215,"startTime":"0","endTime":"0","summary":"Shares of GeneDx Holdings (WGS) surged 5.11% in intraday trading on Wednesday, following a series of positive analyst actions. The genetic testing company saw its stock price climb as several...","market":"sg","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"movement","news_rank":0,"length":0,"strategy_id":0,"source":"ai_movement_en","symbols":["WGS"],"gpt_icon":0},{"id":"2579973106","title":"GeneDx Holdings Is Maintained at Buy by BTIG","url":"https://stock-news.laohu8.com/highlight/detail?id=2579973106","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579973106?lang=en_us&edition=fundamental","pubTime":"2025-10-29 17:57","pubTimestamp":1761731820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/WGS/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  October 29, 2025 05:57 ET (09:57 GMT)","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["WGS"],"gpt_icon":0},{"id":"2579016926","title":"U.S. RESEARCH ROUNDUP-ATI, GoDaddy, Lyft","url":"https://stock-news.laohu8.com/highlight/detail?id=2579016926","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579016926?lang=en_us&edition=fundamental","pubTime":"2025-10-29 15:24","pubTimestamp":1761722665,"startTime":"0","endTime":"0","summary":"U.S. RESEARCH ROUNDUP-ATI, GoDaddy, LyftOct 29 (Reuters) - Wall Street securities analysts revised their ratings and price targets on several U.S.-listed companies, including ATI, GoDaddy and Lyft, on","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nL4N3WA0O8:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ET","CAR","DORM","BOH","GLW","LU1721427968.SGD","BK4512","ECL","LU0868494617.USD","AXTA","ABCB","BBNX","IVZ","AOS","LU1720051108.HKD","NTLA","INCY","BK4541","LU2413666004.HKD","DHI","AWI","BK4567","CZR","BKNG","CAKE","CAC","IQV","EFSC","EW","BK4097","BK4211","FTAI","CRS","CVLT","FSBC","BMRC","CLW","RNA","HRI","CURB","ARQT","ENPH","ESQ","LU0882574055.USD","AMT","WGS","GDDY","ATI","ARCC"],"gpt_icon":1},{"id":"2579925347","title":"GeneDx Holdings Corp : Btig Raises Target Price to $165 From $140","url":"https://stock-news.laohu8.com/highlight/detail?id=2579925347","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579925347?lang=en_us&edition=fundamental","pubTime":"2025-10-29 14:51","pubTimestamp":1761720718,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20251029:nFWN3WA0AR:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4196","WGS"],"gpt_icon":0},{"id":"2579928150","title":"Genedx Holdings Corp. Maintains Stable Risk Profile in 2025 Reports","url":"https://stock-news.laohu8.com/highlight/detail?id=2579928150","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2579928150?lang=en_us&edition=fundamental","pubTime":"2025-10-29 14:01","pubTimestamp":1761717691,"startTime":"0","endTime":"0","summary":"Genedx Holdings Corp. (WGS) has disclosed a new risk, in the Regulation category. Genedx Holdings Corp. has not reported any significant changes to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genedx-holdings-corp-maintains-stable-risk-profile-in-2025-reports?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genedx-holdings-corp-maintains-stable-risk-profile-in-2025-reports?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4196","WGS"],"gpt_icon":0}],"profile":{"websiteUrl":"http://ir.genedx.com","stockEarnings":[{"period":"1week","weight":0.0167},{"period":"1month","weight":-0.1727},{"period":"3month","weight":0.0889},{"period":"6month","weight":0.4312},{"period":"1year","weight":0.6616},{"period":"ytd","weight":0.0111}],"compareEarnings":[{"period":"1week","weight":-0.0002},{"period":"1month","weight":0.003},{"period":"3month","weight":0.0278},{"period":"6month","weight":0.102},{"period":"1year","weight":0.1618},{"period":"ytd","weight":0.0085}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It also provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. is headquartered in Stamford, Connecticut.","yearOnYearQuotes":[{"month":1,"riseRate":0.666667,"avgChangeRate":0.1492},{"month":2,"riseRate":1,"avgChangeRate":0.457595},{"month":3,"riseRate":0.2,"avgChangeRate":-0.132973},{"month":4,"riseRate":0.2,"avgChangeRate":-0.003121},{"month":5,"riseRate":0.4,"avgChangeRate":-0.013957},{"month":6,"riseRate":0.6,"avgChangeRate":0.029191},{"month":7,"riseRate":0.8,"avgChangeRate":0.138059},{"month":8,"riseRate":0.2,"avgChangeRate":-0.136267},{"month":9,"riseRate":0.2,"avgChangeRate":-0.072401},{"month":10,"riseRate":0.8,"avgChangeRate":0.18872},{"month":11,"riseRate":0.2,"avgChangeRate":-0.130294},{"month":12,"riseRate":0.333333,"avgChangeRate":-0.04765}],"exchange":"NASDAQ","name":"GeneDx Holdings","nameEN":"GeneDx Holdings"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"GeneDx Holdings,WGS,GeneDx Holdings股票,GeneDx Holdings股票老虎,GeneDx Holdings股票老虎国际,GeneDx Holdings行情,GeneDx Holdings股票行情,GeneDx Holdings股价,GeneDx Holdings股市,GeneDx Holdings股票价格,GeneDx Holdings股票交易,GeneDx Holdings股票购买,GeneDx Holdings股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"GeneDx Holdings(WGS),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest GeneDx Holdings(WGS) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction